Concepedia

Daniel Yannicelli

DY

Statistics

Publications

7

Citations

453

H-Index

7

Active since

2004

Affiliations

Janssen Scientific Affairs (United States)(Current)

Janssen (United States)

Cleveland Clinic

Group for Research in Decision Analysis

Daniel Yannicelli is an author at Janssen Scientific Affairs (United States) specializing in medicine, anticoagulation management, and antithrombotic therapy.

Publications per year

2004–2018

7

Publications

7

Characterizing Major Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Pharmacovigilance Study of 27 467 Patients Taking Rivaroxaban

Sally Tamayo, W. Frank Peacock, Manesh R. Patel et al. · Clinical Cardiology · 2015 · 150 citations · Full text

, , +17

Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis

Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic et al. · Research and Practice in Thrombosis and Haemostasis · 2017 · 140 citations · Full text

, , +17

Effectiveness and safety of anticoagulants for the treatment of venous thromboembolism in patients with cancer

Michael B. Streiff, Dejan Milentijevic, Keith R. McCrae et al. · American Journal of Hematology · 2018 · 94 citations · Full text

, , +17

Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting

Peter R. Kowey, Daniel Yannicelli, Ezra A. Amsterdam · The American Journal of Cardiology · 2004 · 23 citations

, , +12

Current Practice Patterns and Patient Persistence on Anticoagulant Treatments for Cancer-Associated Thrombosis

Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic et al. · Blood · 2015 · 22 citations

, , +17

1–5 of 7